Focus
drugmaker
Allergan’s Bold Patent Move Could Transform Pharma Landscape
Pharmaceutical giant Allergan struck a bold and unusual deal to protect its patents on a lucrative eye drug in September.
Drugmaker Lilly’s 2016 Forecast Misses Street Expectations
Eli Lilly has dropped a lower-than-expected 2016 forecast on Wall Street after wrapping up a year in which its stock soared above the broader market
